Cargando…

1181. Use of the Combination Antibiogram in the Era of MDR Gram-Negative Pathogens

BACKGROUND: Combinations of two or more antimicrobial agents are frequently used in empiric therapy regimens to ensure at least one agent demonstrates activity against suspected pathogens. A combination antibiogram can assess the increase in empiric coverage of a particular combination vs. either of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klinker, Kenneth, Cherabuddi, Kartikeya, Redell, Mark, Balogh, Matthew, Massey, Jill, Dudley, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252466/ http://dx.doi.org/10.1093/ofid/ofy210.1014

Ejemplares similares

1253. Optimization of empiric gram-negative infections with the combination antibiogram
por: Leung, Anthony K, et al.
Publicado: (2023)

2425. Clinical and Microbiologic Outcomes Among Patients With Monomicrobial Stenotrophomonas maltophilia Infections
por: Klinker, Kenneth, et al.
Publicado: (2018)

719. Cefiderocol Retains Anti-Biofilm Activity in MDR Gram-Negative Pathogens
por: Pybus, Christine A, et al.
Publicado: (2019)

Impact of an Extended Infusion Β-lactam Strategy on Outcomes in Critically Ill Patients with Pseudomonas Infections
por: Klinker, Kenneth, et al.
Publicado: (2017)

356. Impact of CLSI Breakpoint Changes on Unit-Specific Combination Antibiograms for Gram-Negative Respiratory Isolates
por: Wangchinda, Walaiporn, et al.
Publicado: (2023)

Activity of Cefepime-Zidebactam against Multidrug-Resistant (MDR) Gram-Negative Pathogens
por: Thomson, Kenneth S., et al.
Publicado: (2019)

1181. Evaluation of the Safety of a Beta-Lactam Allergy Protocol
por: Sakowski, Alexandra K, et al.
Publicado: (2023)

Antibiogram and Genetic Characterization of Carbapenem-Resistant Gram-Negative Pathogens Incriminated in Healthcare-Associated Infections
por: Makharita, Rabab R, et al.
Publicado: (2020)

Antimicrobial stewardship and antibiograms: importance of moving beyond traditional antibiograms
por: Klinker, Kenneth P., et al.
Publicado: (2021)

1548. Characterizing Cefepime Neurotoxicity: Experience from a Tertiary Care Center Performing β-lactam Therapeutic Drug Monitoring
por: Nys, Cara, et al.
Publicado: (2019)

The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
por: Karaiskos, Ilias, et al.
Publicado: (2019)

103. Empiric Antibiotic Susceptibility Using a Traditional vs. Syndromic Antibiogram-Implications for Antimicrobial Stewardship Programs
por: Klinker, Kenneth, et al.
Publicado: (2020)

443. The CHROME Study, a Real-World Experiential Registry of the Use of Oritavancin for Treatment of Gram-Positive Infections
por: Redell, Mark, et al.
Publicado: (2019)

1243. Acceptable susceptibility thresholds reported in hospital antibiograms for Gram-negative rod infections: a survey and contingent valuation study of infectious diseases providers
por: Hasegawa, Shinya, et al.
Publicado: (2023)

1671. Activity of Imipenem/Relebactam and Comparators Against Gram-Negative MDR and DTR Pathogens from Patients with Respiratory and Bloodstream Infections – SMART United States 2018-2020
por: Lob, Sibylle, et al.
Publicado: (2022)

The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
por: Wolfensberger, Aline, et al.
Publicado: (2019)

Treatment of Infections Due to MDR Gram-Negative Bacteria
por: Bassetti, Matteo, et al.
Publicado: (2019)

1237. New York State Outpatient Regional Antibiogram for Urinary Pathogens: Have We Reached a Post Antibiotic Era for the Treatment of UTIs?
por: Rank, Elliot, et al.
Publicado: (2018)

Early appropriate diagnostics and treatment of MDR Gram-negative infections
por: Bassetti, Matteo, et al.
Publicado: (2022)

Evaluating Patient-Specific Antibiograms
por: Overly, Shannon, et al.
Publicado: (2017)

162. The Genotypic Antibiogram: Using Results of Gram-Negative Antimicrobial Resistance Genes Identified via Rapid Blood Culture Identification Tests to Optimize Treatment of Enterobacterales Bloodstream Infections
por: Sunagawa, Shawnalyn, et al.
Publicado: (2023)

Comparison of an Emergency Department-Specific Antibiogram to Hospital Antibiogram: Influence of Patient Risk Factors on Susceptibility
por: Miller, Jessica, et al.
Publicado: (2017)

Inhibition and Reduction of Biofilm Production along with Their Antibiogram Pattern among Gram-Negative Clinical Isolates
por: Shrestha, Ojaswee, et al.
Publicado: (2023)

2182. Harnessing Direct-from-Blood MALDI-TOF (DBM) and Local Blood Stream Infection (BSI) Antibiogram Data to Direct Optimal Therapy for Gram-Negative Rod (GNR) Bacteremia
por: Tischendorf, Jessica, et al.
Publicado: (2019)

1545. Gram-Negative Bacteremia in Neutropenic Patients: Risk Factors for Mortality in the Era of Multiresistance
por: Herrera, Fabián, et al.
Publicado: (2018)

Fungal Planet description sheets: 1112–1181
por: Crous, P.W., et al.
Publicado: (2020)

Editorial: The Prevalence of MDR Non-Fermenting Gram Negative Bacteria and Their Chemotherapy
por: Chen, Moutong, et al.
Publicado: (2021)

1181. Spectrum and Risk Factors of Early Onset versus Late Onset Neonatal Candidemia from Pakistan
por: Rattani, Salima, et al.
Publicado: (2020)

1578. Treatments for complicated urinary tract infections (cUTI) caused by multidrug resistant (MDR) Gram-negative (GN) pathogens- a systematic review and network meta-analysis (NMA)
por: Reason, Tim, et al.
Publicado: (2020)

P31 Frequency, resistance pattern and antibiogram of bacterial pathogens isolated in Yastebsheron Hospital, Khartoum, Sudan
por: Altahir, Mihad, et al.
Publicado: (2023)

2048. Antibiogram Use in Wisconsin Nursing Homes
por: Taylor, Lindsay N, et al.
Publicado: (2019)

The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections
por: Busani, Stefano, et al.
Publicado: (2017)

Is fosfomycin as effective as claimed on MDR Gram-negative bacteria causing UTI? [Letter]
por: Singh, Geeta, et al.
Publicado: (2019)

Interplay between Phenotypic Resistance to Relevant Antibiotics in Gram-Negative Urinary Pathogens: A Data-Driven Analysis of 10 Years’ Worth of Antibiogram Data
por: Gajdács, Márió, et al.
Publicado: (2021)

Determining the Risk of Antimicrobial Resistance in Common Gram-Positive and Gram-Negative Pathogens After Antibiotic Exposure
por: Hudson, Nicholas, et al.
Publicado: (2015)

In Vitro Activity of Cefiderocol against Multi-Drug Resistant Carbapenemase-Producing Gram-Negative Pathogens
por: Boyd, Sandra, et al.
Publicado: (2017)

983. Pathogen-specific PET/CT imaging for Gram negative implant-associated spinal infections
por: Gordon, Oren, et al.
Publicado: (2022)

Risk of acquiring drug-resistant (MDR) Gram-negative isolates with previous exposure to antibiotic
por: Bhakta, A, et al.
Publicado: (2010)

Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence
por: Garg, Suneel Kumar, et al.
Publicado: (2017)

“Is Fosfomycin As Effective As Claimed On MDR Gram-Negative Bacteria Causing UTI?” [Response To Letter]
por: Gopichand, Pallam, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8ktv2dd0huop8u87irmqshkj5t